These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4326495)

  • 1. [Orientational animal experiments on the toxicity, resorption and effect of a mixture of proteolytic enzymes].
    Stojanow G; Weigelt O; Maehder K
    Wien Tierarztl Monatsschr; 1971; 58(5):193-203. PubMed ID: 4326495
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reinforcement of the chemotherapy of inoperable bronchopulmonary neoplasms by proteolytic enzymes].
    Wrbka E; Kondras B
    Wien Med Wochenschr; 1978 Mar; 128(5):153-8. PubMed ID: 645086
    [No Abstract]   [Full Text] [Related]  

  • 3. [Spectrum of antineoplastic agents in ascites hepatoma--hypothesis on application of the results of animal experiments to human cancer in screening of antineoplastic agents].
    Sato H; Ichimura H
    Nihon Rinsho; 1971 Jul; 29(7):1818-26. PubMed ID: 4338289
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancers of the large bowel and hepatobiliary tract.
    Treat J; Woolley PV
    Cancer Chemother Biol Response Modif; 1991; 12():469-89. PubMed ID: 1657090
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action of intratumoral by administered proteolytic enzymes on the spontaneous mammary adenoma of female Sprague-Dawley rats].
    Weigelt O
    Arzneimittelforschung; 1974 Apr; 24(4):549-56. PubMed ID: 4408028
    [No Abstract]   [Full Text] [Related]  

  • 6. [In vitro cytotoxicity of rabbit and guinea pig antisera against the Zajdela ascites hepatoma in the rat].
    Krüger W
    Acta Biol Med Ger; 1973; 30(6):863-74. PubMed ID: 4357703
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral methotrexate therapy of gastrointestinal carcinoma.
    Moertel CG; Reitemeier RJ; Hahn RG
    Surg Gynecol Obstet; 1970 Feb; 130(2):292-4. PubMed ID: 4189074
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental study on combined therapy with anticancer drugs and urokinase.
    Saito T; Wakui A; Yokoyama M; Kobayashi Y; Kikkawa J
    Sci Rep Res Inst Tohoku Univ Med; 1973 Dec; 19(4):138-45. PubMed ID: 4358525
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical study for augmentation of efficacy of anticancer drugs. 1. Combination therapy by proteolytic enzyme and anticancer drugs].
    Kikuchi K; Aneha Y; Natsume R; Kanno H; Kunii Y
    Nihon Gan Chiryo Gakkai Shi; 1972 Dec; 7(4):270-8. PubMed ID: 4676339
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intra-arterial infusion treatment in lung neoplasms].
    Kokron O; Olbert F; Schlegl A
    Onkologie; 1980 Aug; 3(4):187-91. PubMed ID: 6999407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy of malignant tumors].
    Witte S
    Internist (Berl); 1968 Sep; 9(9):365-75. PubMed ID: 4918656
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of compounds on a spectrum of rat tumors.
    Sugiura K; Schmid FA; Schmid MM; Brown GF
    Cancer Chemother Rep 2; 1972 Nov; 3(1):231-308. PubMed ID: 4350013
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of N-alkyl-N-nitrosourea on the protein-synthesizing system of liver and hepatoma 22a cells].
    Abakumova OIu; Ugarova TIu; Pilipenko NN; Kutsenko NG; Lerman MI
    Biull Eksp Biol Med; 1973 Oct; 75(10):51-4. PubMed ID: 4360614
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical management of advanced gastrointestinal cancer.
    Moertel C
    Semin Drug Treat; 1973; 3(1):55-68. PubMed ID: 4351814
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone) on a spectrum of mouse and rat tumors.
    Mihich E; Gelzer J
    Cancer Res; 1968 Mar; 28(3):553-8. PubMed ID: 4966648
    [No Abstract]   [Full Text] [Related]  

  • 16. Towards a rational chemotherapy of cancer.
    Weber G
    J Indiana State Med Assoc; 1967 Apr; 60(4):417-20. PubMed ID: 4292540
    [No Abstract]   [Full Text] [Related]  

  • 17. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
    Dominguez MF; Macias RI; Izco-Basurko I; de La Fuente A; Pascual MJ; Criado JM; Monte MJ; Yajeya J; Marin JJ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1106-12. PubMed ID: 11356935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of high levels of anti-proliferative nucleoside triphosphates to CYP3A-expressing cells as a potential treatment for hepatocellular carcinoma.
    MacKenna DA; Montag A; Boyer SH; Linemeyer DL; Erion MD
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):981-91. PubMed ID: 19283354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of amsacrine in patients with hepatoma: a Cancer and Leukemia Group B study.
    Amrein PC; Richards F; Coleman M; Poulin RF; Holland JF; Weinberg V; Perry M
    Cancer Treat Rep; 1984 Jun; 68(6):923-4. PubMed ID: 6329510
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental findings concerning the antineoplastic drug fluordopan].
    Larionov LF; Bukharova IK
    Vopr Onkol; 1971; 17(5):78-81. PubMed ID: 4333111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.